Sana Biotechnology IncNASDAQ:SANA
- LAST PRICE4.6800
- TODAY'S CHANGE (%)-0.2400 (-4.8780%)
- Bid / Lots4.6000/ 9
- Ask / Lots5.2200/ 1
- Open / Previous Close4.7400 / 4.9200
- Day Range
- 52 Week Range
- Volume641,236
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SANA |
|---|---|---|
| 09:32 ET | 6732 | 4.715 |
| 09:33 ET | 828 | 4.8585 |
| 09:37 ET | 1479 | 4.87 |
| 09:39 ET | 200 | 4.895 |
| 09:42 ET | 2642 | 4.84 |
| 09:44 ET | 2073 | 4.855 |
| 09:46 ET | 1100 | 4.87 |
| 09:48 ET | 550 | 4.91 |
| 09:50 ET | 100 | 4.91 |
| 09:51 ET | 200 | 4.92 |
| 09:55 ET | 900 | 4.93 |
| 09:57 ET | 600 | 4.92 |
| 10:00 ET | 200 | 4.9 |
| 10:02 ET | 787 | 4.86 |
| 10:04 ET | 1500 | 4.84 |
| 10:06 ET | 914 | 4.835 |
| 10:08 ET | 480 | 4.85 |
| 10:09 ET | 3812 | 4.85 |
| 10:13 ET | 300 | 4.89 |
| 10:15 ET | 1175 | 4.9 |
| 10:18 ET | 700 | 4.9 |
| 10:20 ET | 3708 | 4.87 |
| 10:22 ET | 2365 | 4.87 |
| 10:24 ET | 800 | 4.88 |
| 10:26 ET | 900 | 4.89 |
| 10:27 ET | 860 | 4.895 |
| 10:29 ET | 1000 | 4.86 |
| 10:31 ET | 1701 | 4.855 |
| 10:33 ET | 400 | 4.87 |
| 10:36 ET | 1000 | 4.9 |
| 10:38 ET | 1400 | 4.87 |
| 10:40 ET | 12536 | 4.85 |
| 10:42 ET | 3743 | 4.83 |
| 10:44 ET | 9610 | 4.84 |
| 10:45 ET | 6448 | 4.85 |
| 10:47 ET | 1200 | 4.86 |
| 10:49 ET | 760 | 4.86 |
| 10:51 ET | 2292 | 4.855 |
| 10:54 ET | 200 | 4.85 |
| 10:56 ET | 1805 | 4.86 |
| 10:58 ET | 985 | 4.82 |
| 11:00 ET | 920 | 4.85 |
| 11:02 ET | 300 | 4.85 |
| 11:03 ET | 300 | 4.84 |
| 11:05 ET | 500 | 4.84 |
| 11:09 ET | 1254 | 4.84 |
| 11:12 ET | 300 | 4.85 |
| 11:14 ET | 1000 | 4.865 |
| 11:16 ET | 7742 | 4.865 |
| 11:18 ET | 6159 | 4.855 |
| 11:20 ET | 100 | 4.855 |
| 11:25 ET | 4605 | 4.845 |
| 11:27 ET | 200 | 4.84 |
| 11:30 ET | 325 | 4.84 |
| 11:32 ET | 1741 | 4.86 |
| 11:34 ET | 500 | 4.85 |
| 11:36 ET | 100 | 4.855 |
| 11:38 ET | 670 | 4.865 |
| 11:39 ET | 1200 | 4.84 |
| 11:41 ET | 400 | 4.85 |
| 11:43 ET | 100 | 4.865 |
| 11:45 ET | 667 | 4.8685 |
| 11:48 ET | 100 | 4.8699 |
| 11:50 ET | 3713 | 4.84 |
| 11:52 ET | 2500 | 4.84 |
| 11:54 ET | 400 | 4.835 |
| 11:57 ET | 300 | 4.84 |
| 11:59 ET | 400 | 4.82 |
| 12:01 ET | 400 | 4.83 |
| 12:03 ET | 100 | 4.83 |
| 12:06 ET | 861 | 4.855 |
| 12:08 ET | 6358 | 4.84 |
| 12:10 ET | 1154 | 4.85 |
| 12:12 ET | 300 | 4.85 |
| 12:14 ET | 200 | 4.85 |
| 12:15 ET | 1700 | 4.865 |
| 12:17 ET | 1631 | 4.865 |
| 12:19 ET | 600 | 4.85 |
| 12:21 ET | 400 | 4.85 |
| 12:24 ET | 1300 | 4.87 |
| 12:28 ET | 2119 | 4.87 |
| 12:30 ET | 2200 | 4.89 |
| 12:32 ET | 500 | 4.89 |
| 12:35 ET | 300 | 4.89 |
| 12:37 ET | 400 | 4.9 |
| 12:39 ET | 200 | 4.89 |
| 12:42 ET | 500 | 4.905 |
| 12:44 ET | 2600 | 4.89 |
| 12:46 ET | 500 | 4.9 |
| 12:48 ET | 100 | 4.9 |
| 12:50 ET | 625 | 4.88 |
| 12:51 ET | 1299 | 4.88 |
| 12:55 ET | 1350 | 4.885 |
| 01:00 ET | 2037 | 4.86 |
| 01:02 ET | 1800 | 4.835 |
| 01:04 ET | 400 | 4.83 |
| 01:06 ET | 600 | 4.84 |
| 01:08 ET | 5309 | 4.81 |
| 01:09 ET | 600 | 4.8 |
| 01:11 ET | 100 | 4.79 |
| 01:13 ET | 2000 | 4.795 |
| 01:15 ET | 700 | 4.805 |
| 01:18 ET | 2199 | 4.79 |
| 01:20 ET | 5939 | 4.78 |
| 01:22 ET | 1704 | 4.78 |
| 01:24 ET | 300 | 4.78 |
| 01:26 ET | 400 | 4.78 |
| 01:31 ET | 500 | 4.77 |
| 01:33 ET | 780 | 4.775 |
| 01:38 ET | 900 | 4.8 |
| 01:40 ET | 200 | 4.8 |
| 01:44 ET | 1360 | 4.77 |
| 01:45 ET | 1300 | 4.77 |
| 01:47 ET | 200 | 4.77 |
| 01:49 ET | 500 | 4.79 |
| 01:56 ET | 200 | 4.8 |
| 01:58 ET | 100 | 4.8 |
| 02:00 ET | 2412 | 4.785 |
| 02:02 ET | 3646 | 4.78 |
| 02:05 ET | 700 | 4.795 |
| 02:09 ET | 1184 | 4.79 |
| 02:12 ET | 600 | 4.78 |
| 02:14 ET | 1000 | 4.78 |
| 02:16 ET | 600 | 4.77 |
| 02:18 ET | 810 | 4.78 |
| 02:20 ET | 1089 | 4.78 |
| 02:21 ET | 500 | 4.79 |
| 02:27 ET | 1200 | 4.7775 |
| 02:30 ET | 300 | 4.775 |
| 02:32 ET | 4439 | 4.775 |
| 02:34 ET | 300 | 4.765 |
| 02:36 ET | 1000 | 4.76 |
| 02:38 ET | 1100 | 4.785 |
| 02:39 ET | 100 | 4.79 |
| 02:41 ET | 355 | 4.785 |
| 02:45 ET | 300 | 4.775 |
| 02:48 ET | 3500 | 4.76 |
| 02:50 ET | 2908 | 4.76 |
| 02:52 ET | 1726 | 4.74 |
| 02:54 ET | 454 | 4.73 |
| 02:56 ET | 200 | 4.74 |
| 02:57 ET | 900 | 4.72 |
| 02:59 ET | 600 | 4.71 |
| 03:01 ET | 100 | 4.7 |
| 03:03 ET | 1146 | 4.68 |
| 03:06 ET | 3900 | 4.7 |
| 03:08 ET | 6300 | 4.715 |
| 03:10 ET | 1903 | 4.715 |
| 03:12 ET | 2600 | 4.72 |
| 03:14 ET | 1355 | 4.715 |
| 03:15 ET | 1629 | 4.72 |
| 03:17 ET | 4060 | 4.75 |
| 03:19 ET | 100 | 4.745 |
| 03:21 ET | 900 | 4.725 |
| 03:24 ET | 1400 | 4.73 |
| 03:26 ET | 2303 | 4.74 |
| 03:28 ET | 4392 | 4.725 |
| 03:30 ET | 2432 | 4.715 |
| 03:32 ET | 3408 | 4.715 |
| 03:33 ET | 535 | 4.705 |
| 03:35 ET | 1100 | 4.71 |
| 03:37 ET | 1900 | 4.705 |
| 03:39 ET | 2951 | 4.7 |
| 03:42 ET | 4972 | 4.715 |
| 03:44 ET | 1042 | 4.71 |
| 03:46 ET | 900 | 4.705 |
| 03:48 ET | 1987 | 4.695 |
| 03:50 ET | 3500 | 4.7 |
| 03:51 ET | 2100 | 4.725 |
| 03:53 ET | 8400 | 4.695 |
| 03:55 ET | 27638 | 4.695 |
| 03:57 ET | 6267 | 4.705 |
| 04:00 ET | 68258 | 4.68 |
Feb 2, 2023
Sana Biotechnology to Present at the Guggenheim Healthcare Talks 5th Annual Oncology Conference, from 4:05PM ET on Thursday Feb 02, 2023 by GlobeNewswire
4:05PM ET on Thursday Feb 02, 2023 by GlobeNewswire
Jan 26, 2023
Sana Biotechnology Says FDA Clears Investigational New Drug Application for SC291 Therapy Study, from 5:40PM ET on Thursday Jan 26, 2023 by MT Newswires
5:40PM ET on Thursday Jan 26, 2023 by MT NewswiresBRIEF-Sana Biotechnology Announces FDA Nod For Human Clinical Trials For Car T Therapy For B-Cell Malignancies, from 5:29PM ET on Thursday Jan 26, 2023 by Thomson Reuters
5:29PM ET on Thursday Jan 26, 2023 by Thomson ReutersSana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC291, a Hypoimmune-modified, CD19-targeted Allogeneic CAR T Therapy for Patients with B-Cell Malignancies, from 4:05PM ET on Thursday Jan 26, 2023 by GlobeNewswire
4:05PM ET on Thursday Jan 26, 2023 by GlobeNewswire
Jan 24, 2023
--Morgan Stanley Adjusts Price Target on Sana Biotechnology to $13 From $15, Maintains Overweight Rating, from 10:42AM ET on Tuesday Jan 24, 2023 by MT Newswires
10:42AM ET on Tuesday Jan 24, 2023 by MT Newswires
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Sana Biotechnology Inc | 892.6M | -2.9x | --- |
Anavex Life Sciences Corp | 878.6M | -18.1x | --- |
Kura Oncology Inc | 913.4M | -6.6x | --- |
Janux Therapeutics Inc | 874.9M | -14.4x | --- |
BioXcel Therapeutics Inc | 851.3M | -6.2x | --- |
POINT Biopharma Global Inc | 838.8M | -9.1x | --- |
Company Information
Sana Biotechnology, Inc. is a preclinical-stage biotechnology company. The Company is focused on creating and delivering engineered cells as medicines for patients. The Company develops in vivo and ex vivo cell engineering platforms for treatment across an array of therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system (CNS) disorders, cardiovascular diseases, and genetic disorders, among others. The Company’s process of repairing and controlling genes in the body, referred to as gene therapy or in vivo cell engineering, requires in vivo delivery of a therapeutic payload and modification of the genome. The Company’s fusogen technology in preclinical studies targets cell surface receptors when combined with delivery vehicles to form fusosomes and allows cell-specific delivery across multiple different cell types. The Company focuses this technology on delivering payloads to T cells, hepatocytes, and hematopoietic stem cells (HSCs).
Contact Information
- Headquarters
- 188 East Blaine Street, Suite 400SEATTLE, WA, United States 98102
- Phone
- 206-701-7914
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Hans Bishop
- President, Chief Executive Officer, Director
- Steven Harr
- Executive Vice Chairman of the Board and Head of SanaX
- Richard Mulligan
- Chief Financial Officer, Executive Vice President
- Nathan Hardy
- Executive Vice President, General Counsel, Company Secretary
- James MacDonald
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $892.6M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 190.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.61 |
Book Value | $3.94 |
P/E Ratio | -2.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
